Literature DB >> 1759174

Autoimmune myelodysplasias.

P A Miescher1, H Favre, P Beris.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1759174

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  10 in total

1.  Myelodysplastic syndrome.

Authors:  Shinji Nakao; H Joachim Deeg; Takayuki Ishikawa; Judith Marsh; Alan List; Masao Tomonaga
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 2.  Refractory anaemias.

Authors:  A K Saraya; P S Dhot; R Saxena
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

3.  Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.

Authors:  Y Novik; L Oleksowicz; P H Wiernik
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

Review 4.  Immune pathophysiology of aplastic anemia.

Authors:  Jaroslaw P Maciejewski; Antonio Risitano; Hoon Kook; Weihua Zeng; Guibin Chen; Neal S Young
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 5.  Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.

Authors:  Neal S Young
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

6.  The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort.

Authors:  Maximilian Stahl; Michelle DeVeaux; Theo de Witte; Judith Neukirchen; Mikkael A Sekeres; Andrew M Brunner; Gail J Roboz; David P Steensma; Vijaya R Bhatt; Uwe Platzbecker; Thomas Cluzeau; Pedro H Prata; Raphaël Itzykson; Pierre Fenaux; Amir T Fathi; Alexandra Smith; Ulrich Germing; Ellen K Ritchie; Vivek Verma; Aziz Nazha; Jaroslaw P Maciejewski; Nikolai A Podoltsev; Thomas Prebet; Valeria Santini; Steven D Gore; Rami S Komrokji; Amer M Zeidan
Journal:  Blood Adv       Date:  2018-07-24

Review 7.  Border between aplastic anemia and myelodysplastic syndrome.

Authors:  Hirohito Yamazaki; Shinji Nakao
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

8.  Immunosuppressive therapy for myelodysplastic syndrome: efficacy of methylprednisolone pulse therapy with or without cyclosporin A.

Authors:  Toshiki Yamada; Hisashi Tsurumi; Senji Kasahara; Takeshi Hara; Michio Sawada; Hisataka Moriwaki
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-10       Impact factor: 4.553

9.  Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy.

Authors:  Takahiro Yamauchi; Haruhisa Shirasaki; Atsushi Kuwata; Taro Yamashita; Shin Imamura; Hiroshi Tsutani; Takanori Ueda
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

Review 10.  Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2013-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.